Hyaluronic acid dermal filler market predicted to be worth $6.04bn (£4.84bn) by 2025

The global hyaluronic acid dermal filler market size is expected to reach $6.04bn (£4.84bn) by 2025, according to a new report by Grand View Research. 

The market is expected to register a compound annual growth rate (CAGR) of 8.31% over the forecast period. This growth can be attributed to the rising importance of quality of life and overall health. Moreover, technological innovations in the industry are likely to boost the market further. 

According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2016 hyaluronic acid-based dermal filler procedures were the second-most preferred injectable across the globe. 

The report suggests that the increasing influence of social media advertisements promoting flawless younger-looking skin is expected to drive the segment further. 

Geographically, North America held the largest market share in 2017 on account of the higher number of minimally invasive cosmetic surgeries performed in the region. However, Asia Pacific is expected to witness the highest CAGR due to growing awareness about applications of minimally invasive techniques in emerging economies, such as China, and increasing disposable income levels. Key players in the market mentioned in the report include Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, Genzyme Corporation, Medicis Aesthetics Holdings and Anika Therapeutics. 

The 100-page research report can be viewed here.